2 Results for "

KRASG13C

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "KRASG13C" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-186086
CAS No.: 2953276-07-6
Target:  

Ras

Research Areas:  

Cancer

RM-041 is a selective, orally active KRAS G13C (ON) inhibitor that forms a covalent complex with KRAS G13C (ON) and Cyclophilin A. RM-041 blocks the binding of RAS effector proteins via steric hindrance, and then covalently binds to Cys-13 to form an irreversible inhibitory complex, thereby inhibiting the proliferation of KRAS G13C mutant cancer cells. RM-041 induces regression of KRAS G13C tumors in cellular and xenograft tumor models. RM-041 exerts a synergistic effect when combined with upstream node inhibitors (such as SHP2 inhibitors). RM-041 can be used for the research of non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-184892
CAS No.: 2953305-55-8
Target:  

Ras Raf PERK p38 MAPK Apoptosis

Research Areas:  

Cancer

RMC-8839 is an orally active selective RAS (ON) G13C inhibitor with a Ki value of 28.3 nM. RMC-8839 disrupts the interaction between KRAS G13C and RAF1 (RBD). RMC-8839 inhibits RAS-MAPK pathway signaling by reducing DUSP6 mRNA levels and pERK levels. RMC-8839 induces cytotoxicity, apoptosis (apoptosis) and antiproliferative effects in KRAS G13C-mutated cells. RMC-8839 induces tumor stasis or regression in mice. RMC-8839 can be used in research related to non-small cell lung cancer .
loading...
    loading...